Dosing patterns, hematologic outcomes, and costs of erythropoietic agents in predialysis chronic kidney disease patients with anemia

Author: Papatheofanis Frank J.   McKenzie R. Scott   Mody Samir H.   Suruki Robert Y.   Piech Catherine Tak  

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.22, Iss.5, 2006-05, pp. : 837-842

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content